Gene · 6781
Papers1,853
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,853
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| STC1 is associated with tumor progression and suppressive niches in laryngeal squamous cell carcinoma. | Transl Cancer Res | 2026 | 42724726 | PubTator, text mining | PubMed |
| STC1 promotes osteogenic differentiation and represses inflammation via inhibition of NF‑κB signaling in mesenchymal stromal cells. | Mol Med Rep | 2026 | 42563690 | PubTator, text mining | PubMed |
| The ISL1-WDR5-H3K4me3-STC1 axis attenuates cerebral ischemia-reperfusion injury. | Int Immunopharmacol | 2026 | 42497659 | PubTator, text mining | PubMed |
| Correction: STC1 promotes colorectal cancer invasion and migration by regulating M2 macrophage polarization via TGF-β1/Smad signaling pathway. | Front Med (Lausanne) | 2026 | 42494460 | PubTator, text mining | PubMed |
| Size in small-for-gestational-age neonates correlates with insulin-like growth factor-binding protein proteolysis and insulin-like growth factor-I bioavailability. | J Endocr Soc | 2026 | 42491477 | PubTator, text mining | PubMed |
| Stanniocalcin 1 promotes gastric cancer progression by activating the PI3K/AKT pathway and inducing M2 macrophage polarization via the JAK2/STAT3/lL-10 axis. | Chin Med J (Engl) | 2026 | 42484012 | PubTator, text mining | PubMed |
| Developing an epithelial signature for prognosis of papillary thyroid carcinoma. | Endocr Relat Cancer | 2026 | 42447050 | PubTator, text mining | PubMed |
| Stanniocalcin 1 at the nexus of calcium homeostasis, IGF signaling, and cancer immunity. | Endocr Rev | 2026 | 42446003 | PubTator, text mining | PubMed |
| Identification of genes differentially expressed in granulosa cells from women with high vs. low ovarian responsiveness. | Front Reprod Health | 2026 | 42358728 | PubTator, text mining | PubMed |
| Establishment of rapid identification methods of menstrual blood based on SHERLOCK technology. | Int J Legal Med | 2026 | 42322398 | PubTator, text mining | PubMed |
| STC1 promotes colorectal cancer invasion and migration by regulating M2 macrophage polarization via TGF-β1/Smad signaling pathway. | Front Med (Lausanne) | 2026 | 42164143 | PubTator, text mining | PubMed |
| Corrigendum to "Knockdown of Stanniocalcin-1 inhibits growth and glycolysis in oral squamous cell carcinoma cells". | Open Life Sci | 2026 | 42136824 | PubTator, text mining | PubMed |
| Study on the anti-lung cancer effects of Gracillin from Reineckia carnea by targeting STC1. | BMC Cancer | 2026 | 42135683 | PubTator, text mining | PubMed |
| Correction: Naoxintong capsule decreases circulating exosomes of miR-382-5p to protect LPS-induced vascular endothelial cell injury by targeting STC1 in vitro. | Front Pharmacol | 2026 | 42093883 | PubTator, text mining | PubMed |
| Stanniocalcin-1 confers neuroprotection against ischemic injury via calreticulin-dependent activation of the CAMKK2/AMPK/GSK-3β/Nrf2 pathway. | J Cereb Blood Flow Metab | 2026 | 42093271 | PubTator, text mining | PubMed |
| Focus on M2-TAMs and gastric cancer: a Mendelian randomization and bioinformatics analysis. | Mol Genet Genomics | 2026 | 42067686 | PubTator, text mining | PubMed |
| Hypoxia and DNA-Repair Radiosensitivity Signatures Are Associated with Radiotherapy-Modified Survival in TCGA Breast Cancer, with External Prognostic Validation of the Hypoxia Score in METABRIC. | BioTech (Basel) | 2026 | 42029580 | PubTator, text mining | PubMed |
| Proteomics Signatures of Chronic Kidney Disease in Hypertension. | Hypertension | 2026 | 42017261 | PubTator, text mining | PubMed |
| Bufalin reverses oxaliplatin resistance in gastric cancer by targeting YBX1 to suppress glycolysis. | Biochem Pharmacol | 2026 | 41991006 | PubTator, text mining | PubMed |
| Cancer-associated fibroblast-derived stanniocalcin 1 promotes cholangiocarcinoma progression and lymph node metastasis. | Fundam Res | 2026 | 41971827 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6781/papers